Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial

BACKGROUND: Rotavirus is the leading cause of severe dehydrating gastroenteritis among children younger than 5 years in low-income and middle-income countries. Two vaccines—Rotavac and Rotasiil—are used in routine immunisation in India. The safety and immunogenicity of these vaccines administered in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanungo, Suman, Chatterjee, Pranab, Bavdekar, Ashish, Murhekar, Manoj, Babji, Sudhir, Garg, Richa, Samanta, Sandip, Nandy, Ranjan K, Kawade, Anand, Boopathi, Kangusamy, Kanagasabai, Kaliaperumal, Kamal, Vineet Kumar, Kumar, Velusamy Saravana, Gupta, Nivedita, Dutta, Shanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464301/
https://www.ncbi.nlm.nih.gov/pubmed/35588754
http://dx.doi.org/10.1016/S1473-3099(22)00161-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464301/
https://www.ncbi.nlm.nih.gov/pubmed/35588754
http://dx.doi.org/10.1016/S1473-3099(22)00161-X

Ejemplares similares